- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Lilly challenged Levitra ad/leavepiece claims including “Works first time in 9 out of 10 men”, “wine and dine”, and “many men prefer”.…
Invokana virtual booth email/microsite breached the Code for incomplete prescribing info, misleading headline claims implying significance, missing Vokanamet generic name, and failure…
GSK’s UK cervical cancer disease awareness field team was initially cleared, but on appeal the cumulative arrangements were ruled to promote an…
Anonymous HCP alleged Saxenda was being sold/promoted to the public via linked companies. Panel found no evidence Novo Nordisk was involved, but…
PMCPA case AUTH/2284/12/09 (Anonymous Nurse v Norgine): no breach found because the matter was outwith the scope of the ABPI Code. Undertaking…
Complaint about a Mirapexin/Sifrol tweet. PMCPA recorded no breach because the matter was outwith the scope of the Code. Undertaking received; no…
Anonymous complaint about a Madrid meeting: a pre-meeting “gala dinner” created a lavish impression and was ruled not secondary to the meeting’s…
Complaint about a Praluent advertorial on the HSJ website alleged it was unsuitable for public access and links/references were problematic. The PMCPA…
Anonymous complaint about a Shire meeting advertised on LinkedIn. PMCPA concluded no breach because the matter was outwith the scope of the…
A MIMS print ad for Strivit-D3 used ‘The Licensed Vitamin D3 of Choice’. PMCPA ruled it implied first-choice status and was misleading/exaggerated…
Guidelines in Practice-hosted Ranexa case study wasn’t disguised online, but the downloadable PDF didn’t clearly show Menarini involvement on the front page,…
An anonymous UK health professional complained Avamys’ generic name was unreadable in a Pulse website banner. PMCPA found breaches of Clauses 4.3…
PMCPA ruled Vifor’s Ferinject site landing page promoted a POM to the public (Clause 26.1) and an HCP claim that Ferinject was…
Employee alleged Jinarc EU risk minimisation materials omitted pregnancy/dehydration info and that Otsuka lacked urgency on patient safety. Panel and Appeal Board…
MSD promoted a diabetes/CVD meeting via a targeted LinkedIn sponsored post. A complainant said a patient saw it and couldn’t register. Panel…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.